Dr. Oxiris Barbot is the Commissioner of Health for New York City, a position she assumed in December 2018. With more than 25 years of experience in public health and healthcare delivery, Dr. Barbot has dedicated her career to achieving health equity and is well poised to lead the nation’s premier health department. As an innovative public health leader, Dr. Barbot has championed addressing health inequities in major cities along the east coast. Most recently, she served as the First Deputy Commissioner of the New York City Department of Health and Mental Hygiene. In this role, she served at the helm of the agency’s efforts to eradicate health inequities across New York City. Such efforts include but are not limited to revamping Take Care New York 2020 (#TCNY2020), the City’s data-driven blueprint for achieving health equity, and spearheading the creation of the Center for Health Equity which operationalizes the Department’s commitment to racial justice, meaningful community engagement, and internal reform. In addition to overseeing the agency’s signature equity initiatives, Dr. Barbot oversaw cross-cutting efforts to bridge the gap between public health and healthcare delivery systems, as well as emergency preparedness, and agency performance measurement. In 2010, Dr. Barbot was appointed to serve as Commissioner of Health for Baltimore City. During her tenure in Baltimore, she led the development of Healthy Baltimore 2015, a robust health agenda dedicated to ensuring that all Baltimore city residents realize their full health potential. Under her leadership, the city of Baltimore witnessed a record reduction in the rate of infant death among many other far-reaching achievements in health. From 2003 – 2010, Dr. Barbot served as the Medical Director of NYC public schools. In this capacity, she spearheaded the development and implementation of an electronic health record system which improved the delivery of health services for over one million children. Prior to her work in NYC, Dr. Barbot served as the Chief of Pediatrics and Community Medicine at Unity Health Care, Inc., a federally qualified health center in Washington, DC. Dr. Barbot received a bachelor’s degree from Yale University and holds a medical degree from the University of Medicine and Dentistry of New Jersey. She completed her pediatric residency at George Washington University’s Children’s National Medical Center.
Alan R. Batkin was Vice Chairman of Eton Park Capital Management, L.P., a global, multi-disciplinary investment firm from 2007 to 2012. Prior to joining Eton Park, he was, from 1990 to 2007, Vice Chairman of Kissinger Associates, a geopolitical consulting company. He is on the Board of Directors of three public companies and is Chairman Emeritus of the International Rescue Committee;; a Trustee and member of the Executive Committee of the New York City Police Foundation; a member of the Board and Executive Committee of the MD Anderson Cancer Center and Chair of the Massachusetts General Hospital Center for Global Health.. Mr. Batkin is a Trustee of The Brookings Institution and a member of the Council on Foreign Relations and a former member of The Trilateral Commission and the Inter-American Dialogue. He received a BS from the University of Rochester and an MBA from NYU.
James (Jim) Boylan joined LEERINK in 2009 as a Senior Managing Director and the Head of Investment Banking. Mr. Boylan has over 20 years of experience in investment banking. Prior to joining LEERINK, Jim was at Merrill Lynch & Co. for 12 years where he was a Managing Director in the healthcare group, covering pharma/biotech, healthcare services and leading the medical device franchise from 2004-2009. From 1997 to 2004, Mr. Boylan was a Managing Director in the Mergers & Acquisitions department at Merrill Lynch & Co., where he focused in healthcare and originated and led many transactions across sectors and structures. Prior to Merrill Lynch & Co., Jim was a Vice President in the healthcare group at Smith Barney. Mr. Boylan’s deal experience includes more than 100 transactions where he has helped his clients complete the full cadre of M&A and financing transactions across the pharma/biotech, medical devices, healthcare services and diagnostics & life science tools sectors. Mr. Boylan earned his MBA from Columbia University in 1994 and a B.S. from Lehigh University in 1989.
As Vice-Chair of the Clinton Foundation, Chelsea Clinton works to drive its vision and programmatic objectives with the goal of creating greater opportunities for people to build better futures for themselves, their families, and their communities. Chelsea is a tireless advocate for expanding access to early childhood education, improving the health and well-being of Americans across the country, providing the next generation of young leaders with the resources they need to turn their ideas into action, and ensuring the empowerment of girls and women is a cross-cutting priority across all of the Foundation’s programs and initiatives. Chelsea also serves on the board of the Clinton Foundation’s affiliated Clinton Health Access Initiative and Alliance for a Healthier Generation. In addition, Chelsea is co-author with Devi Sridhar of “Governing Global Health: Who Runs the World and Why?”, and author of “It’s Your World: Get Informed, Get Inspired & Get Going” and “She Persisted: 13 American Women Who Changed the World”. Chelsea holds a Bachelor of Arts from Stanford, a Master of Public Health from Columbia's Mailman School of Public Health, and both a Master of Philosophy and a Doctorate in international relations from Oxford University. She lives with her husband Marc, their daughter Charlotte, and their son Aidan in New York City.
Julie Fisher Cummings has dedicated over 40 years to serving her community both locally and nationally. Ms. Cummings served for five years as a Presidential appointee and board member of the Corporation for National and Community Service. She has also served on the board of the Children’s Hospital of Michigan, as chairman of the board of the Council of Michigan Foundations, and as vice chair of the board of the Max M. and Marjorie S. Fisher Foundation. Ms. Cummings is the founder of Lovelight Foundation, which is a member of Women Moving Millions. Its projects focus on issues such as domestic child sex trafficking and quality early childhood education for disadvantaged children. She is a founding member of two Jewish Women’s Foundations and serves on the Advisory Council of the Ms. Foundation and two nascent national collaboratives that address early childhood education and domestic child sex trafficking. She recently received an MSW from Columbia and teaches a graduate course on Child Policy at the University of Miami.
Charles M. Diker is the managing partner of Diker Management LLC, founded in 2002, where he is a registered investment advisor managing various small and micro-cap funds. He is the chairman of the board of Cantel Medical Corp., a NYSE listed company that markets and manufactures infection control products, and a director of the Loews Corporation. Currently, Mr. Diker is the founding chairman of the National Museum of the American Indian–New York, the George Gustav Heye Center (GGHC), and is a trustee of New York Public Radio, Poly Prep Country Day School, and the Solomon R. Guggenheim Museum. He is the former president of the American Friends of the Israel Museum. After graduating with honors from Harvard College, Mr. Diker received his MBA from Harvard Business School. He and his wife, Valerie, reside in Manhattan.
Jean Drouin, MD, is the founder and CEO of Clarify Health Solutions, which enables health systems, payers, and life sciences organizations to deliver more satisfying and efficient care through advanced analytics, machine learning, and digital care optimization solutions. Prior to Clarify, Jean was a Senior Partner at McKinsey & Company, where his roles included leading the global Healthcare IT and Digital Practice, setting up the UK and Australian Healthcare Practices, and serving as the founding Head of McKinsey Advanced Healthcare Analytics (MAHA). He also served as Head of Strategy for NHS London, which oversaw London’s $15B hospital and primary care system. In these roles, he served over 20 countries and 100 health systems and payers on engagements that generated over $1B in efficiency and quality improvements. Jean is passionate about transforming healthcare delivery across the continuum of care. He has written and spoken extensively on value-based care, population health, new payment models and the role of big data and analytics in delivering better outcomes. Jean holds MD and MBA degrees from Stanford and an AB in Molecular Biology from Princeton. He is the former Vice-Chair of Lester B. Pearson United World College of the Pacific.
Ms. Dina Dublon is a board member of PepsiCo and TRowe Price Group. She is co-chair of Columbia University, Herbert Irving Cancer Center Advisory Council and member of Mailman School of Public Health’s Board of Overseers. She served on the supervisory board of Deutsche Bank 2013-2018 and on the boards of Accenture 2002-2017 and Microsoft 2005-2014 and was on the faculty of Harvard Business School in 2011-12. She was co-chair of the Women’s refugee Commission and on the board of Global Fund for Women. Ms. Dublon was until the end of 2004 EVP and CFO of JPMorgan Chase, responsible for global financial management and related operations, strategy and acquisitions, corporate treasury, tax and investor relations. She played a key role in negotiations and merger integration of Chemical Bank with Manufacturers Hanover, Chase, JPMorgan, and Bank One. Prior to joining the bank, Ms. Dublon worked at the Harvard Business School and at Bank Hapoalim in Israel. She was on the Fortune list of the 50 most powerful women in business for several years and has been honored as a “Woman Who Makes a Difference” by many organizations. Born in Brazil, Ms. Dublon holds a Bachelor’s degree in economics and mathematics from the Hebrew University in Jerusalem and a Master’s degree from the Business School at Carnegie Mellon University. She is married and has two adult children.
Dr. Xue Fang is currently a member of President’s Advisory Council, and a member of Graduate School Dean’s Leadership Council of Princeton University. She also serves as a director in Teach for China, Inc. Born in Beijing, China, Xue studied Biology in Beijing University before attending Graduate School of Princeton University in 1988 to study Neuroscience. She received a Ph.D. in Neuroscience and Psychology in 1995 from Princeton University and a MS in Biostatistics from Columbia University School of Public Health in 1998. She has participated in medical research projects and has worked as a biostatistician in Schering-Plough, a pharmaceutical company in New Jersey. Xue has special interest in education and enjoys reading extensively.
The Rev. Dr. James Alexander Forbes, Jr., is senior minister emeritus of The Riverside Church and president of the Healing of the Nations Foundation. Forbes, who was installed as the fifth Senior Minister of Riverside on June 1, 1989, and retired on June 1, 2007, was the first African-American to serve as senior minister of this multicultural congregation. He is an ordained minister in the American Baptist Churches and the Original United Holy Church of America. He earned a Doctor of Ministry Degree from Colgate-Rochester Divinity School, a Master of Divinity Degree from Union Theological Seminary, and a BA from Howard University, and has received numerous honorary degrees.
George Fotiades is the President & CEO of Cantel Medical Corporation. Most recently he served as Operating Partner in the healthcare investment practice at Five Arrows Capital Partners (Rothschild & Co), a private equity investment firm. Previously he was with Diamond Castle Holdings, where Fotiades served in a similar capacity since 2007. Before joining Diamond Castle in 2007, Fotiades spent 10 years with Cardinal Health, Inc., the Fortune 20 leading provider of products and services supporting the health care industry, and served as its president and COO. Earlier, he was president & CEO of Cardinal's Pharmaceutical Technologies and Services segment, where he formed the largest outsource provider of services to the pharmaceutical industry. This business is today Catalent Pharma Solutions (NYSE: CTLT). Prior to Cardinal Health, Fotiades was president of Warner-Lambert's U.S. consumer health business and previously served as general manager of Bristol Myers Clairol retail business and later as president of their consumer businesses in Japan. He began his career at The Procter & Gamble Co. Fotiades serves on the board of ProLogis, the leading global provider of distribution facilities (NYSE: PLD), AptarGroup (NYSE: ATR), the leading global supplier of dispensing systems for consumer and healthcare products, and Cantel Medical Corp. (NYSE: CMD), a leading provider of infection prevention and control products. Fotiades holds BA degree in economics from Amherst College and a master's degree from the Kellogg School of Management at Northwestern University.
Linda P. Fried, MD, MPH, is Dean and DeLamar Professor of Public Health at the Mailman School, professor of Medicine at Columbia’s College of Physicians & Surgeons and senior vice president at Columbia University Medical Center. Dr. Fried is a geriatrician, epidemiologist, and internationally renowned scientist who has propelled our understanding of how to create healthy aging and set the basis for a transition to an aging world that benefits all ages. She has led the scientific work to define the medical syndrome of frailty and its causes and prevention as keys to optimizing health, and is the co-designer and founder of Experience Corps. Prior to becoming dean in 2008, Dr. Fried served as director of the Division of Geriatric Medicine and Gerontology and of the Center on Aging and Health at The Johns Hopkins University. Dr. Fried is also the recipient of numerous awards including the French National INSERM International Prize in Medical Research, and was named a “Living Legend in Medicine” by the U.S. Congress. She is an elected member of the National Academy of Medicine and past President of the Association of American Physicians. Dr. Fried was named in 2014, one of the most influential scientific minds of the past decade by Thompson Reuters, and the New York Times has called her one of the 15 world leaders in science.
Roslyn (Roz) Goldstein is a prominent New York philanthropist. She is currently a board member of Evelyn Lauder’s Breast Cancer Research Foundation and the American Friends of the Israel Museum. Mrs. Goldstein is the national commissioner of the Anti-Defamation League and serves on the board of the American Friends of Jordan River Village, a camp for seriously ill Jewish, Christian and Muslim children founded by actor Paul Newman. Mrs. Goldstein was formerly president of the United Jewish Federation of Greater Stamford and Darien (CT), a trustee of the Healthcare Chaplaincy, Inc., and president of the Samuel Waxman Cancer Research Foundation. She also was a Board of Overseer of the Albert Einstein College of Medicine of Yeshiva University, where she and her late husband named the Roslyn and Leslie Goldstein Laboratory for Stem Cell Biology and Regenerative Medicine. She is a recipient of an Honorary Doctorate from Yeshiva University.
Sherwin Z. Goodblatt is the retired CEO of the Westwood/ Pembroke Corporation, a behavioral healthcare group operating two hospitals and several partial hospital sites, as well as Veritas, a medical management group. Since his retirement, Mr. Goodblatt has operated a consulting group serving mental health facilities. Mr. Goodblatt is an alumnus of the Columbia University Mailman School of Public Health. He was the 1994 recipient of the Mailman School Dean’s Distinguished Service Award for individuals who have demonstrated outstanding contributions to public health in their professional endeavors and leadership in the field. Mr. Goodblatt had a long teaching career at Providence College, Rutgers University, and Columbia University. He has been a member of the board of directors of Bournewood Health Systems, the National Association of Behavioral Health Systems, and the Massachusetts Association of Psychiatric Health Systems. He was president and a founding board member of Massachusetts Behavioral Health Systems.
South African Adrian Gore is the founder and Chief Executive Officer of Discovery, a multinational financial services group. Discovery is a global thought leader in consumer-driven insurance and the integration of behavioral change with health and life and short-term insurance. It serves over six million customers worldwide. Mr. Gore chairs the South African chapter of Endeavor, a global non-profit organization that identifies and assists high-growth entrepreneurs. He sits on the World Economic Forum Global Health Advisory Board, which is committed to improving global healthcare, the Brookings Advisory Board, and on the Massachusetts General Hospital Global Health Advisory Board. Mr. Gore graduated from Wits University in 1986.
Pete Groves is a Sr. Managing Director and SVP at Publicis Sapient, focused on Digital Business Transformation in the healthcare sector. He joined Publicis Sapient from McKinsey & Company, where he was a Partner in the healthcare practice and in New Ventures, the venture arm investing in building new technologies and intellectual property. Prior to McKinsey, Pete was on the senior management team at the hedge fund Bridgewater Associates; he previously was an Executive Director at the education firm Kaplan, Inc., and the non-profit LIFT Communities. Pete attended Yale University and Columbia Business School, and lives in the greater New York City area with his wife and 2 children.
For the past fifty years, Warren Haber has served as Chairman of the Board and CEO of Founders Equity and its affiliates, private investment concerns. A native New Yorker, he is a Baruch College graduate and attended NYU graduate school. He began his career in Finance at Merrill Lynch. Mr. Haber is a Director of CoStar Group and also serves on the board of a number of privately held companies. Mr. Haber’s wife, Suellen, is an art dealer and formerly had a gallery in Soho but now works exclusively with private clients. Mr. Haber is active in the philanthropic sector and serves as a Trustee on the Board of Leadership Enterprise for Diverse Americans, which mentors and assists under-privileged students through the college application process and post-graduation. He also serves as a Member of Council of The University Club and former Chair of the Finance Committee. He is also a Trustee of Temple Emanu-El and a member of the Investment Committee.
Dr. Y.K. Hamied is Non-Executive Chairman of Cipla, and represents the second generation of Cipla’s founding family. A world-renowned scientist, Dr. Hamied obtained his PhD in organic chemistry in 1960 from the University of Cambridge and joined Cipla in the same year as an R&D Officer. Dr. Hamied was appointed Managing Director of Cipla in 1976 and became Chairman in 1989. He retired as Managing Director on 31st March 2013 and continues to be the Non-Executive Chairman since 1st April 2013. For close to 60 years, Dr. Hamied has been an insightful R&D leader, and an outspoken statesman of global pharma. From affordable HIV drugs to enabling one of the world’s largest portfolio of drugs and devices in inhalation therapy, his pioneering work and contribution to healthcare have been celebrated worldwide. For his distinguished service to the pharmaceutical industry, in 2005, Dr. Hamied was awarded the Padma Bhushan by the Government of India. In 2013, he was named by NDTV as one of India’s 25 Greatest Global Living Legends, and in 2014, the University of Cambridge awarded him a D.Sc, the highest honour bestowed by the University. In 2017, Columbia University’s Mailman School of Public Health conferred the ‘Public Health Hero Award’ on Dr. Hamied, and in 2018, the India Today publication named him one of ‘20 Global Indians’ who have challenged convention. Dr. Hamied has received several lifetime achievement awards, he is an Honorary Fellow of the Royal Society of Chemistry, and frequently features on high-level international healthcare panels.
Robert Harvey is a Director and member of the program, investment and audit committees of the Milbank Memorial Fund, a public health foundation established in 1905 by his ancestress Elizabeth Milbank Anderson. He is also an owner and former director of the Ashforth Company, a commercial real estate and investment company in Stamford, CT where he was chairman of the Board’s audit and compensation committees and a member of its investment committee. He serves as treasurer and a director of the Deering Foundation and a Trustee of the Judson Memorial Church. From 1994-2004, he was President of Barrett Associates, Inc., investment managers in NYC. Previously, he was director of U.S. Equity Investments for Bessemer Trust Co., and a Managing Director of Scudder, Stevens & Clark. Mr. Harvey is a graduate of the Middlesex School and of Bowdoin College. He earned his MPH from the Mailman School and MBA from the University of Virginia and holds the CFA designation.
Andrew is the Founder/CEO of Heff Holding BV, an investment and advisory company. Founded in 2009. Heff Holding is focused on the retail and fashion industry and has invested in over 20 brands to date, including Bonobos, Everlane, Refinery29 and Stance amongst others. In 2014, the company created and launched its first in-house brand called Beltology, a digital native, vertically integrated, single category brand focused on the belt category. Through this experience, Andrew has seen first-hand what it takes to build a brand from scratch. Before pursuing a career in business, he trained as doctor (graduating in 1998 with an MD from Royal College of Surgeons in Ireland), and completing his internship at Beaumont Hospital in Dublin. Following his completion of his studies and prior to founding Heff Holding BV, Andrew worked as both an investment banker at Goldman Sachs in London and as a strategy consultant with Bain & Company based both in Boston & Amsterdam. Andrew is also a graduate of the fashion marketing program at Parsons School of Design and he received his MBA from Harvard Business School in 2006. More recently, Andrew has guest lectured at Parsons in New York, Polimoda in Florence and the Amsterdam Fashion Institute where he teaches the students both finance and strategic brand management.
Thomas Campbell Jackson is a Venture Partner at Easton Capital Investment Group. He has over 25 years of experience in health policy and health economics, including as Director of New York City’s Employee Health Benefits Program, which arranges health coverage for over a million city employees and retirees. He has worked in think tanks and consulted on health policy and insurance matters. Mr. Jackson has served on the Board of Directors of Nanotronics Imaging, Cell Machines, Inc., and other tech startups, and is also an active producer of works in film and theatre. He serves on the Board of Governors of the New York Academy of Sciences; the Board of Directors of the Galen Institute; and the boards of numerous arts and sciences organizations, including Imaginal Disc Productions and the Bellevue Literary Press. He is also President of the Brandt Jackson Foundation. Mr. Jackson received his MPH from Columbia; studied at the Eberhard-Karls Universität Tübingen, Germany; and earned a BA from Tufts University.
Frank R. Jimenez is vice president, general counsel and corporate secretary of Raytheon Company (NYSE: RTN). He is a member of Raytheon’s senior leadership team and participates in the operational management and strategic planning of the company. Prior to joining Raytheon, he served as general counsel, secretary and managing director, Corporate Affairs of Bunge Limited, a Fortune Global 200 agribusiness and food company. He previously served as general counsel of two S&P 500 companies (ITT Corporation and its spinoff Xylem Inc.), as well as General Counsel of the Navy. He has held positions in the U.S. Department of Defense, U.S. Department of Housing and Urban Development, Office of the Governor of Florida and in private legal practice. He received an MBA from the Wharton School of the University of Pennsylvania, a JD from the Yale Law School, a Master’s from the U.S. Naval War College, and a BS from the University of Miami.
Ellen Kaden retired in 2015 after a 38-year career in business, law and academia. For almost 17 years, she served as the chief legal officer of Campbell Soup Company, where she managed the global Legal Department, the Office of Government Affairs, and the Public Affairs and Corporate Social Responsibility groups. Prior to joining Campbell, Ms. Kaden was Executive Vice President and General Counsel of CBS. Earlier in her career, she was a member of the Faculty of Law at Columbia University, and then practiced law at Cravath, Swaine & Moore in New York. Ms. Kaden is a Trustee Emerita of Columbia University, where she served as the Chair of the Audit Committee. She has also served on the boards of the Institute for Judicial Administration and the Columbia University Press, and as a member of the Corporate Advisory Committee of the National Legal Aid and Defender Association and the Steering Committee of the International Rule of Law Council of the Lawyers Committee for Human Rights. Ms. Kaden earned her B.A. from Cornell University, where she was named the Cornelius W. De Kiewet Scholar, and her M.A. from the University of Chicago as a Graduate Fellow of the Danforth Foundation. After earning her J.D. from Columbia Law School, she was a law clerk to Hon. Marvin E. Frankel of the United States District Court for the Southern District of New York.
Ann Kaplan is a partner of Circle Wealth Management, a registered financial advisory firm, focusing on wealth management. She is also the chair and founder of Circle Financial Group, an investment management membership group. She taught asset management at Columbia Business School prior to becoming a University Trustee. Ms. Kaplan was previously a general partner of Goldman, Sachs & Co. She currently serves on the board of the Goldman Sachs Bank USA. Ms. Kaplan is a Columbia University Trustee Emerita. She serves on the Board of Overseers of the Columbia University School of Business and the Board of Advisors at the Medical Center. She is Chair of the Women Creating Change Leadership Board. Ms. Kaplan also serves as a board member of the American Red Cross in Greater New York and the Museum of Arts and Design. She is a member of the Council on Foreign Relations, the Economic Club of New York, the Belizean Grove and the International Women’s Forum. Ms. Kaplan holds a B.A. from Smith College and a M.B.A. from Columbia University.
Sid Lerner is the Chairman and Founder of The Monday Campaigns. He started Meatless Monday in 2003 and since then the campaign has grown into a global movement with programs in 35 countries and with participation from thousands of restaurants, schools, worksites, communities and celebrities. Mr. Lerner’s long and varied career includes working as a creative director in advertising on classic brands such as P&G’s Charmin and Johnson’s Pledge, producing six non-fiction books, including Monday Morning Quarterback, and heading his own creative consulting business—Sid Lerner Associates. Mr. Lerner is also President of BioRings LLC, a non-hormonal contraceptive/STD product he co-invented with two Weill Cornell Medical researchers. In 2011 the Public Health Association of New York City awarded him the Special Merit Award for his development of creative public health marketing strategies. In 2013, he received the Dean’s Medal from Johns Hopkins Bloomberg School of Public Health and the Syracuse University Arents Award, their highest alumni award.
Josh Mailman is an active investor in the most game-changing for-profit and nonprofit enterprises he can find. He believes we must assist in advancing a re-imagining of how finance can advance positive societal change. Currently, Mr. Mailman is Managing Director of Serious Change L.P., a $70M impact investment vehicle started in 2006. Serious Change invests in early-stage companies committed to environmental sustainability, diversity, advancing social justice, and meeting human needs. He also founded Social Venture Network with Wayne Silby of Calvert Group in 1987 as well as the Threshold Foundation (1981) and Business for Social Responsibility (1992). Mr. Mailman’s other nonprofit board activities include Echoing Green, the Fund for Global Human Rights, and the Calvert Foundation.
Phyllis Mailman attended Radcliffe College and is vice president of the Mailman Foundation and of the Joshua Mailman Foundation. She and her late husband, Joseph L. Mailman, were principal donors to the Mailman Research Center at the McLean Hospital in Belmont, Massachusetts, and to the Mailman Center for Child Development at the University of Miami. In 1998, the Mailman Foundation made a generous gift to name the Joseph L. Mailman School of Public Health at Columbia University. In addition to sitting on the Board of Overseers for the Mailman School, Mrs. Mailman is also on the board of Lincoln Center Theatre.
Cyrus Massoumi is Managing Partner and Founder of humbition, an early stage venture firm focused on NYC startups. Prior to humbition, Cyrus founded Zocdoc where he led the company for 8 years as CEO. Earlier in his career, he worked at the global management consulting firm McKinsey & Company, where he gained extensive experience in healthcare technology and new product development. Cyrus is a graduate of Columbia Business School, where he earned an MBA with honors and received the Heffernan Award for Outstanding Service, and the Exemplary Leadership Award, and the Wharton School at the University of Pennsylvania, where he earned a Bachelors of Science with honors. Cyrus has been recognized by both Fortune and Crains on their 40 under 40 lists and by Fast Company as one of the Most Creative People in Business.
Martin Oppenheimer practiced law for more than 50 years at the Proskauer firm. He specialized in labor and employment law representing Fortune 500 companies, served as chair of the labor and employment department of the firm and lectured and wrote extensively in his field. Most of his time is now spent in the not-for-profit arena including serving as Board Member of the 92nd Street YMHA, the N.Y. Road Runners, the Emelin Theatre and as Emeritus Chairman of City Center of Music and Drama and Director Emeritus of Lincoln Center for the Performing Arts. Mr. Oppenheimer graduated from Yale Law School and attended Goethe University in Germany as a Fulbright Scholar.
Perri Peltz is a documentary filmmaker, journalist and public health advocate who most recently directed the HBO documentary, "WARNING: THIS DRUG MAY KILL YOU," about the opioid addiction epidemic. She also co-produced and co-directed the HBO documentary, "Risky Drinking," a no-holds-barred look at alcohol use. She co-directed "A Conversation About Growing Up Black" as part of the "Conversation on Race" series for The New York Times Op-Docs. Other films include HBO's "Remembering the Artist: Robert De Niro, Sr.," "The Education of Dee Dee Ricks," "Prison Dogs" and "A Journey of a Thousand Miles: Peacekeepers." Perri hosts "The Perri Peltz Show" and "Doctor Radio Reports" is for the SiriusXM satellite network. Before working in documentary films, Perri was an award-winning broadcast journalist for NBC, ABC, and CNN. She is currently a doctoral candidate at Columbia University's School of Public Health and attended Brown University.
Mary Lake Polan served as the chair of the Department of Obstetrics and Gynecology at Stanford’s School of Medicine and is currently a Clinical Professor of Obstetrics, Gynecology Reproductive Medicine at Yale University. Dr. Polan served on the board of Wyeth Pharmaceuticals and currently serves on the boards of Quidel Corp and several privately held life sciences companies. She chairs a Scientific Advisory Board on Women’s Health for Proctor and Gamble and several other advisory boards of private life sciences companies. She is a Managing Director of Golden Seeds, an angel investing group which invests in women-led companies. A member of the Institute of Medicine, Dr. Polan has a long-standing interest in women’s health research and international public health. She founded The Eritrean Women’s Project to repair fistulas resulting from traumatic births. She received her BA from Connecticut College, her PhD in Molecular physics and chemistry and MD from Yale, and her MPH from the University of California, Berkeley.
Lila Preston is a partner at Generation Investment Management, a global investment management firm focused on long term sustainable investing (www.generationim.com), where she joined in 2004. At Generation, she Co-Heads the firm’s Growth Equity strategy, helping to scale sustainable solutions businesses. Prior to joining Generation, Lila was a Director of Finance & Development at VolunteerMatch in San Francisco, and also a consultant for clients such as Save the Children (YouthNoise). Prior to joining VolunteerMatch, she was a Fulbright Fellow in Southern Chile where she worked on community-based forestry and conservation projects. Lila graduated with honors from Stanford University with a BA in English and Latin American Studies. She also received an MBA from the London Business School. Lila is also a World Economic Forum Young Global Leader. Lila speaks fluent Spanish. Lila serves as a Board Director for CiBO Technologies, Recyclebank, and Seventh Generation’s Social Mission Board, as well as Board Observer for Optoro and Toast.
Dr. John Rowe is Julius B. Richmond Professor of Health policy and Aging in the Department of Health Policy and Management at the Columbia University Mailman School of Public Health. Previously he served as Chairman and CEO of Aetna, Inc., President and Chief Executive Officer of Mount Sinai NYU Health, the Mount Sinai Hospital and the Mount Sinai School of Medicine in New York City. Before joining Mount Sinai, Dr. Rowe was a Professor of Medicine and the founding Director of the Division on Aging at the Harvard Medical School. He led the MacArthur Foundation Research Network on Successful Aging and currently leads the Foundation’s Network on An Aging Society. Dr. Rowe is a fellow of the American Academy of Arts and Sciences and a member of the Institute of Medicine of the National Academy of Sciences. He serves on the Board of Trustees of the Rockefeller Foundation.
Rajiv is an investor and strategic advisor in the food and agribusiness sector, serving corporations, funds, entrepreneurs, and professionals with a focus on innovation, value creation, and corporate finance. He serves as the co-Chairperson for FoodShot Global, a moonshot style challenge program he helped found, designed to address key problems in the food sector to make it more healthy, sustainable and equitable. He formerly served as CEO of Rabobank North America, where he established deep relationships with leaders, owners, and management at companies in the food, agribusiness, commodities and energy sectors, collaborating with them in investments, financing, capital markets, and corporate transformation transactions. As CEO, Rajiv was responsible for corporate banking, private equity and venture capital, mergers and acquisitions, specialized products, food and agribusiness research, capital markets activities, as well as all operational and support functions. He launched a number of innovation platforms while at the bank, focused on addressing challenges in the food sector. He has been the chair or member of principal risk committees focused on equity, credit, compliance, and reputation. As a special focus on food sector innovation, he led the launch of platforms like Foodbytes and MIT Food Prize (pitch competitions in the food and agribusiness sectors), and Terra (a science and technology-focused accelerator program for Food/Ag entrepreneurs with large corporates as sector partners). Prior to Rabobank, Rajiv had a career in investment banking and special situations investing at Deutsche Bank and Credit Suisse, and in corporate strategy and project operations at United Technologies and Nestle, Rajiv is a graduate of Indian Institute of Technology and Harvard Business School.
Until May 2018 Jonathan Smidt was a partner at Kohlberg Kravis Roberts & Co. At KKR, Mr. Smidt was most recently the head of the Industrials Investment team and member of the Investment Committee within KKR’s Private Equity platform in Europe. Prior to moving to Europe with KKR in February 2016, Mr. Smidt was based in New York and part of KKR’s North American Private Equity team. Prior to joining KKR in 2000, Mr. Smidt was in Goldman Sachs’ Investment Banking Division in New York. Mr. Smidt started his career at Ernst & Young in Cape Town, South Africa. He holds a B.B.S. and a Postgraduate Diploma in Accounting from the University of Cape Town. He is a member of the board of Team Rubicon USA and member of the Council on Foreign Relations.
Diana Taylor is currently Vice-Chair of Solera Capital, LLC. She previously served as managing director at Wolfensohn Fund Management L.P., a strategic consulting and investment firm. Prior to Wolfensohn, she served as New York State superintendent of banks and chairwoman of the New York State Banking Board. Before her government service, she worked in the private sector as vice president for KeySpan Energy and as an investment banker with Smith Barney, Lehman Brothers, and Donaldson Lufkin & Jenrette. Ms. Taylor serves on the boards of Citigroup, Brookfield Asset Management and Sotheby’s. She also serves on several charitable boards. She chairs the boards of Accion and Hudson River Park Trust. Other board memberships include the New York Women’s Foundation, the YMCA of Greater New York, Dartmouth College, the International Women’s Health Coalition and the Mayo Clinic. She is also a member of the Council on Foreign Relations and the Economic Club of New York. She earned her AB from Dartmouth College, her MBA from Columbia School of Business and and her MPH from the Mailman School of Public Health at Columbia University.
Linda Tharby is Executive Vice President of Customer Experience at Becton Dickinson (BD). She leads a cross-company Global Customer Experience Council, comprised of leaders from across the functions, regions and businesses that focuses on a prioritized view of customers’ needs that shape the company’s value offers and ongoing process improvements. Ms. Tharby has served in every aspect of the BD matrix as a regional, business and functional leader. She began her BD career as a key account manager and later served as Country General Manager for Canada. She held several business leadership roles, including worldwide President, Diabetes Care, and Group President, Pre-analytical Systems and Biosciences, before leading the Life Sciences Segment as Segment President.
Ercument Tokat is a Partner and a founding member of the Healthcare Practice at Centerview Partners, a leading independent investment banking firm specializing in general advisory, mergers and acquisitions, divestitures, and principal investing with offices in New York, London, San Francisco and Los Angeles. Mr. Tokat has advised numerous clients on a broad range of strategic advisory assignments and transactions exceeding $200 billion in value across developed and emerging markets. He serves on the board of the International Rescue Committee (IRC) and is a member of the Global Leadership Council at The Brookings Institution. Mr. Tokat is also a Vice-Chair of the Child Health Initiative under the Office of the UN Secretary-General’s Special Envoy for Financing the Health Millennium Development Goals. Mr. Tokat received his BA from Bogazici University and MA from Columbia.
Leonard Tow is Chief Executive Officer of New Century Holdings, LLC. From 1990 to 2004, Dr. Tow was Chairman and Chief Executive Officer of Citizens Communications Company, a wireline telephone company. He was Founder, Director, and Chief Executive Officer of Century Communications Corp., a cable television company, from its incorporation in 1973 until its sale in 1999. Dr. Tow taught at Columbia University’s Graduate School of Business and at Brooklyn and Hunter Colleges of the City University of New York. Dr. Tow also served for several years as Distinguished Adjunct Professor at New York University’s School of Business.
Nancy Mensch Turett is an innovator in cross-sector, pan-generational health engagement. In Spring 2018, Ms. Turett joined APCO Worldwide as its first Chief Health Strategist, to advise and partner with leaders of enterprises in the vanguard of health, healthcare, and life science innovation, and to continue her thought leadership on health, business and society. Through WholeView, the consultancy she established in 2013 to focus on holistic strategies that benefit individuals, enterprise and society, she has worked with World Bank Group, United Nations, MDG Alliance, World Health Organization, Roll Back Malaria, We Own TV, C(ancer)-Change, Robert Wood Johnson Foundation, International Vaccine Institute, Rockefeller Foundation, BCG, Merck, and Omnicom. In two decades at Edelman, Ms. Turett built the communications industry’s pace-setting global health practice, forging deep relationships with clients and partners worldwide. She was the founding leader of signal firm-wide initiatives for thought leadership research and IP, global practices, strategic programming, global citizenship, and service excellence; and managed major operations in the US, Canada and Latin America. Ms. Turett’s previous employment includes Mount Sinai, University of Virginia Medical Center, and US Head Start. Since 2007, Nancy has been a member of the Board of Overseers of the Columbia University Mailman School of Public Health, where she is a Chair of the Enterprise Strategy Committee. Nancy is a member of the Advisory Board for Project HEAL, and previous board/committee work includes the World Economic Forum’s Global Education Initiative, American Diabetes Association, American Cancer Society, NYU’s Center for Aging and Dementia, Resolve Fertility Association, and her alma mater, Princeton University. Ms. Turett’s mission is to inspire and empower health leadership that takes a WholeView of priorities now and for future generations.
Debra Whitman, AARP’s Chief Public Policy Officer, leads policy development, research, and global thought leadership advancing the interests of individuals 50+ and their families. An economist, Dr. Whitman is a strategic thinker dedicated to solving problems affecting economic and health security, among other issues. As Staff Director for the U.S. Senate Committee on Aging, she worked across the aisle to increase retirement security, preserve a strong system of Social Security, lower health care costs, and protect vulnerable seniors. Dr. Whitman holds a Masters and Doctorate in Economics from Syracuse University and Bachelors in Economics, Math and Italian from Gonzaga University.
Betsy Williams is the Founder and Co-Chair of Emerging Public Leaders which is building a new generation of civil service leaders in Africa to help accelerate Africa's development and economic growth. EPL builds on the success the President’s Young Professionals Program in Liberia which Ms. Williams founded while working with then Minister of Health Dr. Walter Winkle, seeing the country's urgent need for a stronger civil service following two civil wars, and recognizing the potential of youth to drive that progress. Ms. Williams' work has focused on the intersection of social development, foreign policy, and global health, having launched and supported innovative programs at USAID, JSI, Asia Society and Physicians for Human Rights. She graduated cum laude from Princeton University and received her MPH from the Mailman School of Public Health at Columbia University where she currently serves as Vice Chair of the Board of Overseers. She is married to Tom Moore and lives in Washington, DC with their two daughters.
Jody Mailman Wolfe is the President of the Mailman Foundation. Retired after nearly 25 years in professional law enforcement, Ms. Wolfe has served on a number of non-profit boards in New York and Miami with a range of interests, including child welfare, foster care, substance abuse prevention, independent school education, and the arts. Ms. Wolfe has long been involved in higher education and currently serves on the board of the American Council of Trustees and Alumni based in Washington, DC. In addition to Columbia University’s Mailman School of Public Health, the Foundation has also been an important benefactor to institutions such as the Mailman Research Center in Psychobiology at Harvard’s McLean Hospital in Massachusetts, the Mailman Center for Child Development at the University of Miami’s Miller School of Medicine and Lincoln Center for the Performing Arts.
Ian Woo is a Managing Director at C-Bridge Capital, a healthcare dedicated private equity firm focused on growth and late stage investment opportunities with $1.7 billion under management. Ian is also the President & CFO of Everest Medicines, a biopharma platform started by C-Bridge Capital that is focused on bringing innovative medicines to Great China and Asia emerging markets across four therapeutic areas: Oncology, Infectious Disease, Renal & Immunology and CNS. Previously, Ian was a managing director in the global healthcare group at Lazard, one of the world's premier financial advisory and asset management firms. He worked with numerous global biopharma companies and led Lazard’s healthcare efforts in Greater China. Ian joined Lazard in 2005 and was based in New York, other than from 2012 to 2016, when he worked in the firm’s Hong Kong office. Ian holds a Master of Business Administration from Columbia University Business School, a Master’s degree in Molecular and Cellular Biology from Columbia University Graduate School of Arts & Sciences and a Bachelor’s degree in Biology from Tufts University. Ian was also a student at Harvard University Graduate School of Arts & Sciences, and conducted research at Harvard Medical School and Brigham and Women’s Hospital, where he was an author on multiple published papers.
Mr. Zabel is a founding partner of Schulte Roth & Zabel and head of its Individual Client Services Group. He has received numerous recognitions including a Lifetime Achievement Award from The American Lawyer, the Eleanor Roosevelt Val-Kill Human Rights Award, Brandeis’ Distinguished Community Service Award, and the Lawyers Committee for Human Rights Extraordinary Leader Award, and the Robert F. Kennedy Justice Prize. Mr. Zabel is a member of the American Law Institute and the Council on Foreign Relations, a Fellow of Brandeis University, American College of Trusts and Estates Counsel and the American Bar Foundation. His civic and philanthropic activities have included chair of Human Rights First, Life Trustee of NYU, The New School, Princeton University Planned Giving Committee. Lincoln Center Theatre, American Academy of Poets, and the Sakharov Archives. Mr. Zabel is recognized as one of the country’s most outstanding Trust & Estates lawyers. He graduated summa cum laude and Phi Beta Kappa from Princeton and cum laude from Harvard Law School.
Susan Lasker Brody is the President of Susan L. Brody Associates, Inc., an art advisory company that provides customized services on the acquisition, sale and appraisal of fine art. Previously, she served as head of Sotheby’s 19th Century European Painting Department and created and built Sotheby’s first Museum Services Department, where she managed and developed all auction sales from museums throughout the U.S. In 1983, she founded her own firm. Ms. Brody is the granddaughter of Albert and Mary Lasker, the Chicago advertising magnate, co-founders of the prestigious Lasker Medical Research Award. With a lifelong family interest in medicine and science, she received an MPH from the School of Public Health, Columbia University in 1997 with a focus on mental health and mood disorders for populations, where she established a scholarship for students from developing countries. Ms. Brody is on the “Leadership Council” of The New York Stem Cell Foundation and is a board member of the Brain & Behavior Research Foundation and The Huntington Library and Gardens, San Marino, California. She earned her BA from Stanford.
Dr. Harris has had a longstanding career in the medical field. He was the vice president of Medical Affairs for the Visiting Nurse Service of New York; the commissioner of the Suffolk County Department of Health; the associate director of Mount Sinai Hospital; and, deputy commissioner of NYC Department of Health. He attended Cornell where he was selected to Phi Beta Kappa, and received his MD from New York University. Dr. Harris is a 1965 alumnus of the Mailman School, and a recipient of Columbia’s Alumni Federation Medal for conspicuous service. In addition to his 40 years on the board of Public Health Solutions, Dr. Harris serves on the boards of several organizations that address issues of medicine, health, home health and hospice care, disposal of low-level radioactive waste, and protection of community water supplies. As a member of the NY State Board for Medicine and the NY State Board of Professional Medical Conduct, Dr. Harris now focuses his professional interests on physician licensure and discipline.
Susan Patricof is a dedicated advocate for at-risk children and for public health. In 1973 she joined the Northside Center’s Board of Directors, in 1993 served as its Chair, and currently serves as President. Northside provides clinical treatment to more than 2500 children and families and in 2005, its Susan E. Patricof Head Start Center opened its doors to 200 children in Harlem. In 1999, Mrs. Patricof became a member of the IRC’s Board of Directors where she has served on its health, nominating and program committees and has co-chaired the Children’s Unit for ten years. Mrs. Patricof also serves on the Board of the Global Foundation for Humanity and is a member of the Council on Foreign Relations.